The individuals listed on this page are the “architects” of the Washington D.C. Declaration-those who helping to draft or review the document and the people whose work has inspired the declaration, making it possible for humanity to contemplate and call for a future, AIDS-free generation.
NOTE: This is a partial list as of July 10, 2012 and will be completed in time for the AIDS 2012 Conference.
Bertrand Audoin, Executive Director of the International AIDS Society
Bertrand Audoin has been the Executive Director of the International AIDS Society since February 2011. He has been working in the HIV field for almost 20 years, and first became involved in the response to the epidemic at grass roots level in the early 1990s. While working at the Alliance Française in Auckland, New Zealand, Bertrand was motivated to volunteer in HIV prevention programmes by the disastrous consequences that he saw the epidemic was having on the family, work and social lives of men and women living with HIV in the local area.
Immediately before joining the IAS, Bertrand was based in Paris for 15 years as the General Director of Sidaction, a leading French HIV/AIDS NGO. Sidaction secured long-term commitments on implementing local prevention and care programmes on both national and international levels.
Bertrand also works with the Pierre Bergé and Yves Saint Laurent Foundation as coordinator of its “Fonds de dotation Pierre Bergé” committee for HIV/AIDS programmes, an organization led by the former founder and co-owner of Yves Saint Laurent company. He is the treasurer of Paris-based NGO “Dessine-moi un mouton”, an organization that helps children and families affected by HIV/ AIDS. He was recently awarded the French Ordre National du Merite in recognition of his contribution to the fight against HIV and AIDS.
Bertrand’s goal over the next few years is to use his role at the IAS to emphasize the importance of multidisciplinary efforts and to harness the organization’s unique power of bringing very different people together to conceive the future of the fight against HIV/AIDS at global and local levels. Bertrand sees the IAS as an instrument to make the “think globally, act locally” motto work, and states that, in a world where many leaders tend to erase the fight against HIV/AIDS from their list of priorities, the IAS is here to make clear that this would be a big mistake for the future of humanity as a whole.
Françoise Barré-Sinoussi, Nobel Prize in Medicine, 2008
Françoise Barré-Sinoussi, PhD, is the acting Director of the “Regulation of Retroviral Infections” Unit in the Department of Virology at the Institut Pasteur in Paris. She is involved in retrovirology research, since the early 1970′s. She is recognized for her contributions to HIV/AIDS research, in particular as the first author of the publication that reported in 1983 the discovery of the cause of AIDS, a retrovirus, later named HIV. In 1988, she became responsible of her own laboratory at the Institut Pasteur and initiated research programs on viral and host determinants of HIV/AIDS pathogenesis. She has also been implicated in collaborative programs on HIV vaccine research, using primate models. Today, the research programs of her team are focused on mechanisms required to protect against HIV/SIV infections and/or against early pathogenic signals induced by HIV/SIV (regulation of viral replication and/or regulation of harmful T cell activation, in particular by components of the innate immunity).
Françoise Barré-Sinoussi has been strongly implicated in promoting integration between HIV/AIDS research and actions in resource limited countries, in particular through the Institute Pasteur International Network and the coordination of the ANRS research programs in Cambodia and Vietnam, according to her strong commitment in building capacity, training and technology transfers on site in Africa and Asia. Françoise Barré-Sinoussi is author and co-author of 270 original publications and of more than 120 articles in book reviews. She has been invited as a speaker more than 270 International meetings and/or conferences. Françoise Barré-Sinoussi has been (and is still) member of a number of French or international scientific committees and societies, including scientific committees of several International AIDS Conferences. In June 2006, Françoise Barré-Sinoussi was elected as an IAS Governing Council member in the European Region. Through her career, she received more than 10 national or international awards, including the Nobel Prize for Medicine in 2008 for her contributions to HIV/AIDS. In february 2009 she was elected member of the French Academy of Science. She will be the next President of the IAS starting from July 2012.
Chris Beyrer, Johns Hopkins University
Chris Beyrer M.D., M.P.H, is Professor of Epidemiology, International Health and Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health in Baltimore. He currently serves as Director of the JHU Fogarty AIDS International Training and Research Program and is the founder and Director of the Center for Public Health and Human Rights at Johns Hopkins. He also serves as Associate Director of the new Johns Hopkins Center for AIDS Research (CFAR), and as Associate Director of the Johns Hopkins Center for Global Health, a consortium of the Schools of Medicine, Public Health, and Nursing. He serves on the Scientific Advisory Board for the U.S. PEPFAR program and on the newly formed MSM Working Group of the HPTN. He currently co-chairs the Office of AIDS Research of the U.S. NIH Natural History and Epidemiology planning committee. In 2008 Dr. Beyrer was elected to the Governing Council of the International AIDS Society as a representative forNorth America and serves on the IAS Executive Committee. He will become President-Elect of the IAS in July at AIDS 2012 in Washington, DC. He is also the IAS regional representative on the Conference Coordinating Committee for AIDS 2012. Dr. Beyrer’s research is focused on HIV among key populations including men who have sex with men and people who use drugs. He currently has research or training activities in Thailand, Burma, Vietnam, Russia, Kazakhstan, Malawi, Ethiopia, South Africa, Uganda, and Tanzania.
Chris Collins, amfAR, the Foundation for AIDS Research
Chris Collins is Vice President and Director of public policy at amfAR, the Foundation for AIDS Research. Collins has spent more than 18 years in HIV/AIDS policy and advocacy. Before joining amfAR, he was a consultant on policy and communications for numerous domestic and global health organizations. In 2007 he authored Improving Outcomes: Blueprint for a National AIDS Plan for the United States, published by the Open Society Institute, and he then helped organize the movement for development of a National HIV/AIDS Strategy for the U.S. As a consultant with the Bill & Melinda Gates Foundation, Collins coordinated the work of the Global HIV Prevention Working Group. He also oversaw production of the series of Missing the Target reports on international AIDS service scale-up produced by the International Treatment Preparedness Coalition (ITPC). Collins is a co-founder of the AIDS Vaccine Advocacy Coalition (AVAC), served as its executive director for two years, and remains on its board. As Appropriations Associate for Rep. Nancy Pelosi in the late 1990s, Collins developed the first Congressional legislation designed to provide incentives for the development and delivery of vaccines against AIDS, malaria, and TB. Collins is the author of dozens of publications on HIV/AIDS policy. He holds a Master’s Degree in Public Policy from the Kennedy School of Government at Harvard University.
Wafaa El-Sadr, Columbia University
Wafaa El-Sadr, MD, MPH, MPA is director of ICAP and of the Global health Initiative at Columbia Mailman School of Public Health and professor of epidemiology and medicine at Columbia University. Through her US-based and global work, Dr. El-Sadr has contributed to the scale-up of prevention and care programs in partnership with in-country and community organizations and stakeholders.Her work is focused on supporting health systems to deliver high quality HIV and related programs as well as conducting research and training activities in the same contexts. She has also led research studies that have contributed to informing the prevention and management of HIV, tuberculosis and related conditions. She received her medical degree from Cairo University in Egypt and master’s degrees from Columbia University and Harvard University.
Beatriz Grinsztejn, Evandro Chagas Clinical Research Institute (IPEC)
Beatriz Grinsztejn is an Infectious Disease Physician and Clinical Researcher with Masters and PhD degrees in Infectious Diseases. As a researcher at Evandro Chagas Clinical Research Institute (IPEC), Oswaldo Cruz Foundation (Fiocruz), she is the head of the STD/AIDS Clinical Research Laboratory and faculty of the Master and Doctorate degree program on Infectious Disease Clinical Research. She is the Principal Investigator of the NIH sponsored Fiocruz Clinical Trials Unit. She is also the Principal Investigator of the HIV Prevention Trials Network, and the AIDS Clinical Trials Group in Rio de Janeiro, the Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet), and is co-PI for the IprEX study at Fiocruz. She is also co-PI of the Brazil-Agence Nationale De Recherches dur le SIDA et les Hépatites Virales (ANRS) Reflate TB trial and a member of the CIHR Canadian HIV Trials Network International Committee. She has been actively participating in pivotal studies for the development of new antiretroviral compounds, of treatment and prevention strategies targeting HIV and co-infections with a special focus on Tuberculosis and HPV. She is currently co-chairing the ACTG third line multinational clinical trial (A5288) in resource limited settings. She has assumed leadership roles in the ACTG Women’s Health Research agenda in the past years and is the Principal Investigator of the HIV infected women’s cohort at IPEC/Fiocruz, launched in 1996, with over 900 women in active follow up, conducting studies on HIV/HPV co-infection and reproductive health. She serves as a member of the Brazilian Ministry of Health Advisory Committee for Antiretroviral Therapy in adults and is also a member of the HIV Research Advisory Board to the Brazilian Ministry of Health. She has been appointed as a member of the 2013 adult WHO Guideline Development Group. She has published more than 100 papers in peer-reviewed scientific journals and served as Advisor for several Master and Doctoral students.
Diane Havlir, UCSF and San Francisco General Hospital and Trauma Center..
Diane Havlir, MD, is Professor of Medicine at UCSF and Chief of the HIV/AIDS Division at San Francisco General Hospital and Trauma Center. She was a physician in training at UCSF when the AIDS epidemic emerged in the 1980s and has cared for HIV- infected patients for over 25 years. She is an active researcher who pioneered some of the first studies of HIV antiretroviral therapy and drugs to prevent AIDS complications. Her recent efforts showed that prompt initiation of antiretroviral therapy in patient with HIV and tuberculosis can significantly reduce mortality and AIDS. She is principal investigator for the ACTG unit at UCSF and the PROMOTE program project which is studying HIV and malaria. She founded the SEARCH collaboration which is evaluating medical, economic and education outcomes of universal HIV therapy through a streamlined delivery approach in East Africa.Dr. Havlir has played an active role on the global stage as an author of the first WHO Global HIV Treatment Guidelines. In concert, she helped establish a Global HIV Drug Resistance surveillance program. She is a member of the Board of the STOP TB partnership and chair of the HIV and TB working group. She served on the Governing Council for the International AIDS Society and is an advisor to the Infectious Disease Center for Global Health Policy. She has won numerous awards including the HIV Medical Association Research Award and the AIDS Research Institute Mentorship Award . She was elected to the American Society for Clinical Investigation. Dr. Havlir is the United States Co-chair of the International AIDS Conference in Washington DC in July, 2012.
Adeeba Kamarulzaman, University of Malaya in Kuala Lumpur, Malaysia.
Adeeba Kamarulzaman is a Professor of Medicine and Infectious Diseases and presently the Dean of the Faculty of Medicine at the University of Malaya in Kuala Lumpur, Malaysia. She has been at the forefront of Malaysia’s HIV response in both its prevention and treatment programmes and was instrumental in initiating the harm reduction programs in her country.Through the Centre of Excellence of Research in AIDS which she established at the University of Malaya, she directs and oversees a multidisciplinary HIV research program focusing on marginalised populations at risk.Dr. Kamarulzaman is a committee member of numerous regional and international organizations and was recently elected onto the IAS Governing Council. In 2013 she will co-host the VIIth IAS Treatment and Pathogenesis Conference in Kuala Lumpur.
Salim S. Abdool Karim, Centre for the AIDS Program of Research in South Africa
Salim S Abdool Karim
Salim S. Abdool Karim, MBChB, PhD is Director of CAPRISA – Centre for the AIDS Program of Research in South Africa and President of the South African Medical Research Council. He is also Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal, Professor of Clinical Epidemiology at Columbia University, Adjunct Professor of Medicine at Cornell University and Associate Member of The Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard University.
Elly T Katabira, Makerere University, Kampala, Uganda
Elly T Katabira
Elly T Katabira, MD, FRCP, Professor of Medicine in the Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. Dr. Katabira received his medical degree at Makerere and went on to specialize in Neurology in England. However, he has been working in the field of HIV as a clinician, an educator and a researcher since 1985. He started the first AIDS clinic in Africa in 1987 and has worked with a number of organizations including WHO, UNAIDS, etc. He also co-founded The AIDS Support Organization (TASO) with others in Uganda in 1987. He joined the IAS in 1990 and in 2000 became the regional representative at the governing council. In July 2010 became the President of IAS and is the International Chair of the International AIDS conference that will take place in Washington DC, 22-27 July, 2012.His research interests are in clinical trials, operational research and ART implementation studies. He has published over 90 papers in peer-reviewed journals and presented over 200 abstracts at international conferences
Joep Lange, University of Amsterdam
Joep Lange is Professor of Medicine at the Academic Medical Center (AMC), University of Amsterdam, where he heads the Department of Global Health and the Amsterdam Institute for Global Health and Development (AIGHD). He has been involved in HIV research and treatment since 1983. In addition to various positions at the AMC, he was Chief of Clinical Research and Drug Development at the Global Programme on AIDS of the World Health Organization in Geneva from 1992 to 1995. From 2002 to 2004 he was President of the International AIDS Society. He has been the architect and principal investigator of several pivotal trials on antiretroviral therapy and prevention of mother-to-child transmission in both the developed and developing world, and has also been one of the leading actors in increasing access to HIV treatment in resource-poor settings.
Sharon Lewin, The Alfred Hospital, Monash University and Burnet Institute, Melbourne, Australia
Professor Sharon Lewin, FRACP, PhD, is an infectious diseases physician and basic scientist. She is Director of the Department of Infectious Diseases The Alfred Hospital and Monash University and co-head of the Centre for Virology, Burnet Institute, Melbourne, Australia. She completed her specialist and PhD training in Melbourne and her post-doctoral fellowship at the Aaron Diamond AIDS Research Centre, The Rockefeller University. She is a past president of the Australasian Society for HIV Medicine and a member of the Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmitted Infections, the peak advisory body to the Australian government on blood borne viruses. She is the local co-chair for the XXth International AIDS Conference which will be held in Melbourne in 2014. Her laboratory focuses on HIV latency and strategies for HIV cure, immune reconstitution on antiretroviral therapy and HIV-hepatitis B virus co-infection
Julio Montaner, University of British Columbia
Julio Montaner, MD, DSc (hon), FRCPC, FCCP, FACP, FRSC, OBC., Professor of Medicine, UBC and St. Paul’s Hospital Foundation Chair in AIDS Research, Head of Division of AIDS, Faculty of Medicine, University of British Columbia; Director, BC Centre for Excellence in HIV/AIDS, St. Paul’s Hospital-Providence Health Care; Past-President, International AIDS Society.
Dr Julio Montaner is originally from Buenos Aires, Argentina. He received his Medical Degree with Honors from the University of Buenos Aires in 1979. In 1981, Dr. Montaner joined the University of British Columbia (UBC) at St Paul’s Hospital (SPH) where he completed his training in Internal Medicine and Respiratory Medicine. While still in training, he led several clinical studies that demonstrated the role of adjunctive corticosteroids in PCP-related respiratory failure. In 1988, he became the Director of the AIDS Research Program and the Immunodeficiency Clinic at SPH/UBC. Since then, he focused his research in the development of antiretroviral therapies and management strategies. In the mid 90’s, he played a key role in establishing the efficacy of NNRTI based highly active antiretroviral therapy (HAART). This was one of the pivotal contributions emerging from the IAS-sponsored Vancouver 1996 International AIDS Conference, of which he was a co-organizer. He is a Professor of Medicine at UBC and has held the Endowed Chair in AIDS Research at SPH/UBC since 1996. He is a founding Co-Director of the Canadian HIV Trials Network. He is the Director of the BC Centre for Excellence in HIV/AIDS. He has been a member of the International AIDS Society since 1988, an elected member of the North American Region since 2002 and President from 2008-2010. Dr. Montaner has authored over 450 scientific publications on HIV/AIDS. His current research interests include HAART as prevention, optimal use of HAART, salvage therapy, new antiretrovirals, as well as hard to reach populations and harm reduction. In 2008, he received the inaugural Avant-Garde Award of $2.5 million over 5 years, from the National Institute on Drug Abuse of the National Institutes of Health (NIH), to support his project entitled “Seek and Treat for Optimal Outcomes and Prevention in HIV & AIDS in IDU (STOP HIV/AIDS)”. In September 2009, he was the recipient of the $100,000 Knowledge Translation Award from the Canadian Institutes of Health (CIHR) and, in November 2009, he was inducted into the Royal Society of Canada-The Academies of Arts, Humanities and Sciences (RSC). Founded in 1882, the RSC, consisting of distinguished Canadian scholars, artists and scientists, is Canada’s senior and most prestigious scholarly organization. In 2010, he received a Doctor of Science honoris causa from Simon Fraser University, the Prix Galien Award, the Order of BC as well as the Albert Einstein World of Science Award.
Olive Shisana, South African Human Sciences Research Council
Olive Shisana, Sc.D. is the Chief Executive Officer of the South African Human Sciences Research Council and previously served as its Executive Director of the Social Aspects of HIV/AIDS and Health, a program she founded. She previously served as Executive Director of Family and Community Health at the World Health Organization in Geneva where she established the WHO HIV/AIDS/STI initiative, and also became a founding member of the Partnership on AIDS in Africa. Dr. Shisana serves on the Board of the Nelson Mandela’s 46664 HIV/AIDS Campaign. She was a lead investigator on a number of national and provincial studies aiming to improve understanding of HIV/AIDS dynamics in South Africa. Currently she serves as President of the Paris-based International Social Sciences Council and a member of the UNESCO High Panel on Science and Technology for Development. She is also a Co-Chair of the Global HIV Prevention Working Group, an international group of scientists who produce actionable recommendations to support prioritization of evidenced-based programs.
Mitchell Warren, AVAC
Mitchell Warren is the Executive Director of AVAC, an international non-governmental organization that uses education, policy analysis, advocacy and a network of global collaborations to accelerate the ethical development and global delivery of AIDS vaccines, male circumcision, microbicides, PrEP and other emerging HIV prevention options as part of a comprehensive response to the pandemic.Previously, he was the Senior Director for Vaccine Preparedness at the International AIDS Vaccine Initiative (IAVI) and also a Vice President and Director of International Affairs for The Female Health Company (FHC), the manufacturer of the female condom. Warren also spent six years at Population Services International (PSI) designing and implementing social marketing, communications and health promotion activities in Africa, Asia and Europe, including five years running PSI’s project in South Africa.Warren studied English and History at the University of Wisconsin-Madison and health policy at the Johns Hopkins University School of Hygiene and Public Health.
Peter Piot, London School of Hygiene & Tropical Medicine
Peter Piot, MD, PhD, is the Director of the London School of Hygiene & Tropical Medicine, and Professor of Global Health. In 2009-2010 he was the Director of the Institute for Global Health at Imperial College, London. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, and was an Associate Director of the Global Programme on AIDS of WHO.
Quarraisha Abdool Karim, Columbia University
Quarraisha Abdool Karim
Quarraisha Abdool Karim, PhD is Associate Scientific Director of CAPRISA, Associate Professor in Clinical Epidemiology at Columbia University, Adjunct Professor in Public Health at University of KwaZulu-Natal, Director of the Columbia University-Southern African Fogarty AIDS Training Program and Co-Chair of Scientific Program for AIDS 2012.
David Ernesto Munar, the AIDS Foundation of Chicago
David Ernesto Munar
David Ernesto Munar Appointed President/CEO in February 2011, David Ernesto Munar brings to his work more than two decades of accomplishments fighting HIV/AIDS.David has worked at the AIDS Foundation of Chicago (AFC) since 1991. He most recently served as the organization’s Vice President, with oversight and management of a $16 million portfolio of care, prevention, and policy programs and services. Throughout his career, Mr. Munar has worked in collaboration with colleagues locally and nationally to nurture innovative responses to the HIV/AIDS crisis.
Under David’s leadership, AFC collaborated with CHAMP and SisterLove to develop the HIV Prevention Justice Alliance, which advocates for cross‐disciplinary responses to the social and structural factors fueling the spread of HIV. In 2007, he helped launch the Coalition for a National AIDS Strategy, which lead to the National HIV/AIDS Strategy unveiled by President Obama in July 2010.
Kevin Moody, Global Network of People Living with HIV
Dr. Kevin Moody, BScPhm, MBA, EdD is the International Coordinator and CEO of the GlobalNetwork of People Living with HIV (GNP+). Since Dr. Moody joined GNP+ in 2006, GNP+ has developed and supported the implementation of evidence-gathering and advocacy tools driven by people living with HIV. Under his leadership, GNP+ has grown into a strong, effective and accountable network representing people living with HIV globally with its roots firmly planted in networks at country level. He supported the Board in a Strategic Review of the organization in 2010, which led to the development of GNP+’s Strategic Plan 2011-2015.
Prior to GNP+, he worked as a Technical Officer for the World Health Organization from 2003-2006, focussing on HIV treatment preparedness, as well as the competency and certification of health workers. From 2000-2002, he worked with the Campaign for Access to Essential Medicines at Médecins Sans Frontières, helping country teams to implement affordable treatment programmes for HIV, TB, malaria and often-ignored tropical diseases, such as Leishmaniasis.
Dr. Moody started his career as a pharmacist in Canada and worked in both community and hospital pharmacies. From 1991-1998, he taught Pharmacy Administration and directed the Continuing Pharmacy Education Programme at the University of British Columbia in Vancouver, where he was awarded the Award of Recognition for Service and the Certificate of Honour by the College of Pharmacists of British Columbia.
Ambassador Mark Dybul, Georgetown University Law Center
Ambassador Mark Dybul co-directs the Global Health Law Program at Georgetown University Law Center’s O’Neill Institute for National and Global Health Law, where he is also a Distinguished Scholar. He is the inaugural Global Health Fellow of the George W. Bush Institute and serves as the Managing Director of the Office of the United Nation Special Envoy for Malaria. Ambassador Dybul served as the United States Global AIDS Coordinator from 2006 to the end of the George W. Bush administration. In that role, he led the implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR), the largest international health initiative in history for a single disease. Ambassador Dybul oversaw the United States government engagement in the Global Fund to Fight AIDS, Tuberculosis and Malaria and was the Chair of the Finance and Audit Committee. He also served as chair of the Joint United Nations Programme on HIV/AIDS’ coordinating board and as a member of the board of trustees of the Woodrow Wilson International Center for Scholars. Prior to assuming the post of Ambassador, he was Acting, Deputy and Assistant Coordinator, and was a member of the Planning Task Force that created PEPFAR. He also led President Bush’s International Prevention of Mother and Child HIV initiative at the Department of Health and Human Services (HHS), was the Executive Secretary for HHS guideline for adult and adolescent HIV therapy and was a member of the writing committee for the World Health Organization’s guidelines on the use of antiretroviral therapy. At HHS, Ambassador Dybul served as the Assistant Director for Medical Affairs at the National Institute of Allergy and Infectious Diseases and the National Institutes of Health, and was one of the principal architects of basic and clinical research with a particular emphasis on HIV treatment in Africa. He is well published in scientific and policy literature, has received several honorary degrees and significant awards, and has served on numerous national and international boards.
Ambassador Dybul received his A.B. in philosophy and M.D. from Georgetown University before completing a residency in Internal Medicine at the University of Chicago Medical Center in 1992 and a fellowship in Infectious Diseases from the National Institute of Allergy and Infectious Diseases in 1995.